Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction

It is to be elucidated the risk-predictive role of differentially expressed fatty acid metabolism related genes (DE-FRGs) in dilated cardiomyopathy (DCM) and myocardial infarction. Four gene enrichment analyses defined DE-FRGs’ biological functions and pathways. Three strategies were applied to identify risk biomarkers and construct a nomogram. The 4-DE-FRG correlation with immune cell infiltration, drugs, and ceRNA was explored. DE-FRGs were enriched in lipid metabolism. A risk nomogram was established by and , demonstrating a good ability for DCM and myocardial infarction prediction. was positively correlated with adaptive immunocytes. Thirty-five drugs are candidate therapeutic targets. A nomogram and new biological targets for early diagnosis and treatment of DCM and myocardial infarction were provided. Dilated cardiomyopathy (DCM) and myocardial infarction (MI) are two common types of heart disease. This study investigated the fatty acid metabolism related genes to predict the risk of DCM or MI. Four of them ( and ) were effective in predicting disease risk. Additionally, was found to be associated with immune cell infiltration, and 35 drugs emerged as potential therapeutic targets for these diseases. This study may provide insights into the early diagnosis and treatment of DCM and MI.